ESMO 2026 has ended. This guide stays up as the record of who was there. Next: ESMO 2027, Sep 17–21, 2027 in Barcelona
AbbVie at ESMO 2026
Oct 23–27, 2026 Madrid, Spain ~37k attendees Website
AbbVie takes part in 2 sessions at ESMO 2026 in Madrid, and exhibits at Booth 8034. Its work spans personalised care in ovarian cancer and drug combinations in non-small-cell lung cancer. One study examines how osimertinib affects the movement of telisotuzumab vedotin inside cancer cells.
| Organization | ESMO 2026 Attendance |
|---|---|
AbbVie North Chicago, IL | |
Global biopharmaceutical company with oncology medicines including venetoclax, ibrutinib and antibody-drug conjugates. | Booth Exhibiting at Booth 8034 Satellite Fri Oct 23 09:45–11:15 AbbVie - Riding the Wave of Innovation Towards Personalized Medicine in Ovarian Cancer Gynaecological cancers Poster Fri Oct 23 13:00–15:00 |
Find decision makers at AbbVie
Tell us what you sell and we’ll find the people at AbbVie most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction